Taken together, the findings suggest oral GLP-1s could: unlock entirely new audiences who previously rejected injections increase treatment uptake among younger adults improve long-term adherence through familiarity and convenience create a substantial switching market among existing GLP-1 users The pill could be the key Oral GLP-1s could completely change the weight loss market in the UK
Kim JE, Park SY, Kwak C, Lee Y, Song DG, Jung JW, et al
Make some changes to your diet Youve got enough going on without having to worry about what youre eating
Additional in vivo and in vitro studies are necessary to verify the involvement of ferroptosis in HD-specific pathologic mechanisms and development
Macronutrient and caloric targets calibrated to each patient's body composition data and activity level, designed to preserve muscle during active weight reduction
Sauer, A., Peukert, K., Putensen, C